SuperworthAltria Group, Inc. MO
Tobacco, Consumer Defensive
$69.38
+1.21%
- Market cap
- $115.8B
- PE
- 14.6×
- 10y median 13.2×
- Forward PE
- Price to sales
- 4.9×
- EV/EBIT
- 12.2×
- Revenue, 12 months
- $23.5B
- −1% on a year ago
- Net margin
- 34.0%
- Free cash flow yield
- 7.9%
Altria trades at 14.6× trailing earnings, near its ten-year median. Revenue was $23.5B over the last twelve months, down 1% on a year earlier with a 34% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $6B | $5.6B | $6.2B | $6.3B | $6B+0% | $5.3B−6% | $6.1B−2% | $6.1B−3% | $5.8B−2% | $5.4B+3% | $6.1B+0% | |
| Cost of revenue | $1.5B | $1.4B | $1.6B | $1.5B | $1.5B−2% | $1.3B−12% | $1.4B−10% | $1.4B−6% | $1.4B−4% | $1.9B+51% | $1.5B+7% |
| Gross profit | $3.5B | $3.3B | $3.7B | $3.8B | $3.6B+3% | $3.2B−1% | $3.9B+5% | $3.8B+0% | $3.6B+1% | $3.5B+8% | $4.6B+19% |
| R&D | $71M | $0 | $0 | $61M | $43M−39% | $0 | $0 | $0 | $0 | $0 | $0 |
| SG&A | $703M | $606M | $788M | $656M | $687M−2% | $588M−3% | $619M−21% | $580M−12% | $720M+5% | $550M−7% | $663M+7% |
| $2.8B | $2.7B | $2.5B | $3.2B | $2.9B+3% | $1.8B−33% | $3.2B+28% | $3.2B+3% | $1.7B−43% | $3B+65% | $3.1B−3% | |
| Interest expense | $231M | $254M | $261M | $267M | $255M+10% | $262M+3% | $275M+5% | $278M+4% | $362M+42% | $258M−2% | $295M+7% |
| Pre-tax income | $2.7B | $2.7B | $5.1B | $3B | $2.8B+2% | $1.7B−39% | $3.1B−39% | $3.1B+2% | $1.5B−46% | $2.9B+70% | $2.9B−6% |
| $675M | $610M | $1.3B | $733M | −$262M | $606M−1% | $740M−44% | $700M−5% | $396M | $676M+12% | $631M−15% | |
| Net income | $2.1B | $2.1B | $3.8B | $2.3B | $3B+48% | $1.1B−49% | $2.4B−38% | $2.4B+4% | $1.1B−63% | $2.2B+103% | $2.3B−3% |
| $1.16 | $1.21 | $2.21 | $1.34 | $1.79+54% | $0.63−48% | $1.41−36% | $1.41+5% | $0.66−63% | $1.30+106% | $1.37−3% | |
| 1.8B | 1.8B | 1.7B | 1.7B | 1.7B−4% | 1.7B−4% | 1.7B−2% | 1.7B−1% | 1.7B−1% | 1.7B−1% | 1.7B−1% |
From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.
Estimates
Next earnings report: .
Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.
Peers
Companies in Consumer Defensive within ten times Altria's size, closest in size first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| MOAltria Group, Inc. | $115.8B | 14.6× | 13.2× | 4.9× | −1% | 34.0% | |
| MNSTMonster Beverage Corporation | $84B | 39.5× | 37.7× | 9.1× | +20% | 23.1% | |
| PEPPepsiCo, Inc. | $168.9B | 16.2× | 25.8× | 1.7× | +6% | 10.8% | |
| MDLZMondelez International, Inc. | $75.8B | 21.8× | 22.5× | 1.9× | +7% | 8.9% | |
| CLColgate-Palmolive Company | $69.5B | 34.6× | 27.2× | 3.3× | +5% | 9.7% | |
| TGTTarget Corporation | $68.6B | 15.7× | 15.7× | 0.6× | +2% | 4.1% | |
| PMPhilip Morris International Inc. | $300.3B | 27.7× | 18.4× | 7.1× | +9% | 25.6% | |
| KDPKeurig Dr Pepper Inc. | $41.6B | 30.8× | 25.0× | 2.1× | +27% | 7.1% | |
| ADMArcher-Daniels-Midland Company | $39.2B | 22.3× | 15.3× | 0.5× | −1% | 2.2% | |
| PGThe Procter & Gamble Company | $343.6B | 22.3× | 25.2× | 3.9× | +3% | 18.4% | |
| SYYSysco Corporation | $36.8B | 21.0× | 24.4× | 0.4× | +4% | 2.1% | |
| Peer median | $72.7B | 22.3× | 24.7× | 2.0× | +5% | 9.3% |
About
- Industry
- Tobacco
- Sector
- Consumer Defensive
Valuation data, not investment advice. Prices as of .